Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2008. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2742683013 | Eltrombopag olamine (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2768571019 | Eltrombopag olamine | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 693171000241114 | eltrombopag olamine (substance) | fr | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Common French translation module (core metadata concept) |
| 808281000172112 | eltrombopag olamine | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Common French translation module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Eltrombopag olamine (substance) | est un(e) (attribut) | Thrombopoietin receptor agonist | true | Inferred relationship | Some | ||
| Eltrombopag olamine (substance) | est un(e) (attribut) | Benzoic acid and/or benzoic acid derivative (substance) | true | Inferred relationship | Some | ||
| Eltrombopag olamine (substance) | est un(e) (attribut) | Hydrazine and/or hydrazine derivative | true | Inferred relationship | Some | ||
| Eltrombopag olamine (substance) | est un(e) (attribut) | Pyrazole and/or pyrazole derivative (substance) | true | Inferred relationship | Some | ||
| Eltrombopag olamine (substance) | Is modification of (attribute) | Eltrombopag (substance) | true | Inferred relationship | Some | ||
| Eltrombopag olamine (substance) | est un(e) (attribut) | Eltrombopag (substance) | false | Inferred relationship | Some | ||
| Eltrombopag olamine (substance) | Has disposition (attribute) | Thrombopoietin receptor agonist (disposition) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely eltrombopag (as eltrombopag olamine) 25 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | True | Eltrombopag olamine (substance) | Inferred relationship | Some | 1 |
| Eltrombopag (as eltrombopag olamine) 12.5 mg oral tablet | Has precise active ingredient | True | Eltrombopag olamine (substance) | Inferred relationship | Some | 1 |
| Eltrombopag (as eltrombopag olamine) 50 mg oral tablet | Has precise active ingredient | True | Eltrombopag olamine (substance) | Inferred relationship | Some | 1 |
| Product containing precisely eltrombopag (as eltrombopag olamine) 75 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | True | Eltrombopag olamine (substance) | Inferred relationship | Some | 1 |
This concept is not in any reference sets
FHIR